Lv01
0 积分 2023-11-17 加入
Feasibility and preliminary safety and efficacy of first-in-human intraperitoneal delivery of MCY-M11, anti-human-mesothelin CAR mRNA transfected into peripheral blood mononuclear cells, for ovarian cancer and malignant peritoneal mesothelioma
1小时前
已完结
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
5小时前
已完结
皖公网安备34019202002308
